This announcement is a separate document:
万辰集团：上海信公轶禾企业管理咨询有限公司关于福建万辰生物科技集团股份有限公司2023年第二期限制性股票激励计划首次授予部分第一个归属期归属相关事项之独立财务顾问报告
Fujian Wanchen Biotechnology Group: Shanghai Xin Gong Yi He Enterprise Management Consulting Co., Ltd.'s independent financial advisor report on the first attribution period of the second phase of the restricted stock incentive plan of Fujian Wanchen Biotechnology Group Co., Ltd. in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated